Aarkstore Aarkstore || Pain Management Therapeutics Market to 2017 - Price

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) November 28, 2011 -- Aarkstore.com announces, a new market research report is available in its vast collection:

Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
http://www.aarkstore.com/reports/Pain-Management-Therapeutics-Market-to-2017-Price-Competition-to-Intensify-Following-Patent-Expiries-of-Lyrica-and-Cymbalta-164675.html



Summary

GBI Research, the leading business intelligence provider, has released its latest research, “Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta”, which provides insights into the global pain management therapeutics market and market forecasts until 2017. The report provides an in-depth analysis of the top eight therapeutic indications for which pain management drugs are often prescribed, which includes fibromyalgia, neuropathic pain, migraine, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post-operative pain. The report also examines the global pain management therapeutics treatment usage patterns for the covered indications. In addition, the report also includes insights into the pain management therapeutics R&D pipeline.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.

The global pain management therapeutics market has huge potential for growth due to the large population that is affected by medically significant pain. The market is growing at a moderate growth rate, driven by the cancer pain, low back pain and post-operative pain relief markets. In 2010, the global pain management therapeutics market was estimated at $28.6 billion, representing a CAGR of 5.3% between 2002 and 2010. The post-operative pain relief market, with sales of $5.9 billion in 2010, accounted for one fifth of the total pain management therapeutics market.

Scope
- Data and analysis on the pain therapeutics market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
- Annualized market data for the pain management therapeutics market from 2002 to 2010, with forecasts to 2017.

- Market data on the therapeutic landscape, which covers fibromyalgia, neuropathic pain, migraine, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post-operative pain therapeutics, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population and treated population.

Reasons to buy
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.


Table of Contents :
1.1 List of Tables 7
1.2 List of Figures 11
2 Pain Management Therapeutics Market - Introduction 17
2.1 GBI Research Report Guidance 18
3 Pain Management Therapeutics Market - Market Overview 19
3.1 Introduction 19
3.2 WHO (World Health Organization) Pain Ladder 21

3.3 Risk Evaluation and Mitigation Strategy (REMS) 22
3.4 Revenue 23
3.5 Major Marketed Pain Management Drugs 24
3.5.1 Lyrica (pregabalin) 25
3.5.2 Cymbalta (duloxetine) 26
3.5.3 Celebrex (celecoxib) 26
3.5.4 Voltaren Gel (diclofenac sodium) 27

For all Related Reports Please follow the link:
http://www.aarkstore.com/search/viewresults.asp?search=Pain Management &PubId=&pagenum=1



For more information, please visit :

Contact: Marketing Team

Ph.No.918149852585

Email : enquiry@aarkstore.com/
URL: http://www.aarkstore.com/

pain management     therapeutics